Indian CDA "in parliament by year's end"
This article was originally published in Clinica
The next steps for India's proposed Central Drugs Authority (CDA) are still unclear, but the recommendations gathered by the parliamentary committee from stakeholders are now expected to be finalised and presented to parliament during its winter session. A meeting is scheduled to take place on an unspecified date this month, with a view to wrapping up the course of action to be taken, reports Pharmabiz. However, the committee is expected to hold further stakeholder meetings across the country after July. The committee, led by Amar Singh, member of the Rajya Sabha (upper house of parliament), is also reportedly debating whether to obtain the direct involvement of RA Mashelkar, a renowned scientist and the namesake of the Mashelkar Committee that had initially proposed amendments to the Drugs & Cosmetics Act, 1940.